SpiditsOpen Live Timeline
Product Launch
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Summary
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a
Why It Matters
Broadens access to advanced AI capabilities for developers and end-users.
Referenced Coverage & Sources
Track AI Developments
See model releases, funding rounds, and technical news on the live interactive timeline.